Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Virios Therapeutics, Inc.

Virios Therapeutics, Inc. (VIRI) Stock Overview

Explore Virios Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

VIRI●NASDAQ
HealthcareBiotechnology
$0.15
$0.02(12.40%)
U.S. Market opens in 35h 3m

Virios Therapeutics, Inc. (VIRI)

Meyka AI Score

Z

Key Financials

Market Cap206.5K
P/E Ratio0.13
EPS (TTM)$-5.75
ROE286.25%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

VIRI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Virios Therapeutics, Inc. (NASDAQ: VIRI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Virios Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of VIRI on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Virios Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of 0.13 and a market capitalization of 206.5K. Combined with our AI analysis, these give both institutional and retail investors a clear view of VIRI on the NASDAQ.

Price Performance (NASDAQ: VIRI)

1-Day Change
N/A
5-Day Change
-96.40%
1-Month Change
-95.51%
3-Month Change
-96.69%
6-Month Change
-98.50%
Year-to-Date (YTD) Change
-98.94%
1-Year Change
-99.11%
3-Year Change
-99.89%
5-Year Change
-99.96%
All-Time (Max) Change
-99.96%

Contact Information

https://www.virios.com
866 620 8655
44 Milton Avenue, Alpharetta, GA, 30009

Company Facts

40 Employees
IPO DateDec 17, 2020
CountryUS

Frequently Asked Questions